Longitudinal Phenotypes of Type 1 Diabetes in Youth Based on Weight and Glycemia and Their Association With Complications.
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 12 2019
01 12 2019
Historique:
received:
27
03
2019
accepted:
03
07
2019
pubmed:
11
7
2019
medline:
29
5
2020
entrez:
11
7
2019
Statut:
ppublish
Résumé
Subclinical and clinical complications emerge early in type 1 diabetes (T1D) and may be associated with obesity and hyperglycemia. Test how longitudinal "weight-glycemia" phenotypes increase susceptibility to different patterns of early/subclinical complications among youth with T1D. SEARCH for Diabetes in Youth observational study. Population-based cohort. Youth with T1D (n = 570) diagnosed 2002 to 2006 or 2008. Participants were clustered based on longitudinal body mass index z score and HbA1c from a baseline visit and 5+ year follow-up visit (mean diabetes duration: 1.4 ± 0.4 years and 8.2 ± 1.9 years, respectively). Logistic regression modeling tested cluster associations with seven early/subclinical diabetes complications at follow-up, adjusting for sex, race/ethnicity, age, and duration. Four longitudinal weight-glycemia clusters were identified: The Referent Cluster (n = 195, 34.3%), the Hyperglycemia Only Cluster (n = 53, 9.3%), the Elevated Weight Only Cluster (n = 206, 36.1%), and the Elevated Weight With Increasing Hyperglycemia (EWH) Cluster (n = 115, 20.2%). Compared with the Referent Cluster, the Hyperglycemia Only Cluster had elevated odds of dyslipidemia [adjusted odds ratio (aOR) 2.22, 95% CI: 1.15 to 4.29], retinopathy (aOR 9.98, 95% CI: 2.49 to 40.0), and diabetic kidney disease (DKD) (aOR 4.16, 95% CI: 1.37 to 12.62). The EWH Cluster had elevated odds of hypertension (aOR 2.18, 95% CI: 1.19 to 4.00), dyslipidemia (aOR 2.36, 95% CI: 1.41 to 3.95), arterial stiffness (aOR 2.46, 95% CI: 1.09 to 5.53), retinopathy (aOR 5.11, 95% CI: 1.34 to 19.46), and DKD (aOR 3.43, 95% CI: 1.29 to 9.11). Weight-glycemia phenotypes show different patterns of complications, particularly markers of subclinical macrovascular disease, even in the first decade of T1D.
Identifiants
pubmed: 31290977
pii: 5530245
doi: 10.1210/jc.2019-00734
pmc: PMC6812733
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
6003-6016Subventions
Organisme : NCCDPHP CDC HHS
ID : U01 DP000247
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002710
Pays : United States
Organisme : ACL HHS
ID : U18DP006138
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000154
Pays : United States
Organisme : NIDDK NIH HHS
ID : F30 DK113728
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002714
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000244
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000062
Pays : United States
Organisme : ACL HHS
ID : U18DP006134
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002709
Pays : United States
Organisme : ACL HHS
ID : U18DP006131
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056350
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000077
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000423
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK119465
Pays : United States
Organisme : HSRD VA
ID : HIR 10-001
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK057516
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : ACL HHS
ID : U18DP006139
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK108173
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000248
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002489
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Organisme : ACL HHS
ID : U18DP006136
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000250
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000246
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001450
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000254
Pays : United States
Organisme : ACL HHS
ID : U18DP006133
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002708
Pays : United States
Informations de copyright
Copyright © 2019 Endocrine Society.
Références
Diabetologia. 2017 Jul;60(7):1234-1243
pubmed: 28439641
Curr Opin Endocrinol Diabetes Obes. 2015 Aug;22(4):277-82
pubmed: 26087341
Diabetes Care. 2011 Jul;34(7):1628-33
pubmed: 21636800
Pediatr Diabetes. 2010 Feb;11(1):4-11
pubmed: 19473302
Arch Intern Med. 2009 Jul 27;169(14):1307-16
pubmed: 19636033
Diabetes Care. 2005 Jan;28(1):186-212
pubmed: 15616254
Curr Diab Rep. 2017 Aug;17(8):58
pubmed: 28660565
Diabetes Care. 2003 Jul;26(7):2194-7
pubmed: 12832334
Diabetes Care. 2005 Jul;28(7):1649-55
pubmed: 15983315
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5195-5204
pubmed: 31034018
Diabetes Care. 2017 Apr;40(4):607-613
pubmed: 28126715
Diabetes Res Clin Pract. 2013 Apr;100(1):126-32
pubmed: 23339757
Diabetes Care. 2019 Jul;42(7):1297-1304
pubmed: 31048408
Diabetes Care. 2013 Aug;36(8):2351-8
pubmed: 23435158
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3265-3278
pubmed: 30938764
Diabetes Care. 2010 Mar;33(3):495-500
pubmed: 20032278
Pediatr Diabetes. 2018 Jun;19(4):794-800
pubmed: 29383813
Lancet Child Adolesc Health. 2019 Jan;3(1):35-43
pubmed: 30409691
Diabetes Metab Syndr Obes. 2018 Apr 27;11:159-173
pubmed: 29731652
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
Obes Res Clin Pract. 2014 Mar-Apr;8(2):e178-82
pubmed: 24743014
Diabetes Care. 1988 Jul-Aug;11(7):567-73
pubmed: 2904881
JAMA. 2015 Dec 1;314(21):2241-50
pubmed: 26624824
Adv Data. 2000 Jun 8;(314):1-27
pubmed: 11183293
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
J Pediatr. 2015 May;166(5):1265-1269.e1
pubmed: 25919735
Pediatr Diabetes. 2018 Nov;19(7):1271-1275
pubmed: 29923262
Pediatr Diabetes. 2004 Mar;5(1):16-9
pubmed: 15043685
Diabetes Care. 2013 Aug;36(8):2198-202
pubmed: 23536586
Ophthalmology. 1986 Sep;93(9):1183-7
pubmed: 3101021
Endocr Rev. 2018 Oct 1;39(5):629-663
pubmed: 30060120
Diabetes Care. 1994 Nov;17(11):1281-9
pubmed: 7821168
JAMA. 2017 Feb 28;317(8):825-835
pubmed: 28245334
Diabetes Care. 2017 Dec;40(12):1756-1762
pubmed: 29138273
Diabetes Care. 2009 Aug;32(8):1384-90
pubmed: 19435955
JAMA. 1998 Jul 8;280(2):140-6
pubmed: 9669786
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Circulation. 2014 Oct 21;130(17):1532-58
pubmed: 25170098
JAMA. 2019 May 21;321(19):1867-1868
pubmed: 30985875
Diabetes Care. 2019 Apr;42(4):657-664
pubmed: 30728218
J Pediatr. 2001 Dec;139(6):804-12
pubmed: 11743505
J Pediatr. 2015 Sep;167(3):627-32.e1-4
pubmed: 26164381
Comput Methods Programs Biomed. 2013 Jan;109(1):104-11
pubmed: 23127283
Vital Health Stat 2. 2003 Sep;(135):1-55
pubmed: 14556588
J Pediatr. 1994 Aug;125(2):177-88
pubmed: 8040759
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6003-6016
pubmed: 31290977